UNSPSC 85532381: Supplement inferior mesenteric vein with autologous tissue substitute, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement inferior mesenteric vein with autologous tissue substitute, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 06U607Z

UNSPSC 85532381 Supplement inferior mesenteric vein with autologous tissue substitute, open approach is a Commodity code that appears to have limited relevance to state and local procurement activity. The recent opportunities posted under this code do not involve surgical vascular procedures or tissue substitutes; instead, they span medical benefit administration, occupational health surveillance, disability retirement medical evaluations, pharmacy benefit management, temporary clinical staffing placement, and youth detention healthcare services — none of which align with the code's nominal scope of vascular surgical intervention.

The issuing bodies in the recent opportunities include city retirement offices (Phoenix), municipal employee benefits programs (Long Beach), state transportation departments (Washington), county juvenile justice systems (Harris County), county health systems (Santa Clara), and county procurement serving health care consortiums (Collier County). Geographic spread includes Arizona, California, Florida, Texas, and Washington. Representative recent opportunities include the City of Phoenix Retirement Office RFP for independent medical evaluation services (due October 16, 2026), the Washington State Department of Transportation RFP for occupational medical surveillance (due October 9, 2026, with pre-bid August 31, 2026), and the County of Santa Clara Health System solicitation for temporary health professional staffing qualification pool (due October 7, 2026). The code shows no decision-relevant procurement signals for firms pursuing vascular surgical services or tissue-substitute suppliers in the state and local market.